Follow the Money

By Author Proscia | June 29, 2022

Proscia, a digital and computational pathology solutions company, has raised $37 million to advance how we understand and treat diseases like cancer. The financing will enable Proscia to accelerate the adoption of computational pathology, strengthening its market and product leadership. It will also use the capital infusion to scale its commercial operation, broaden its portfolio of computational solutions, build on its DermAI and AI melanoma detection success, and extend digital pathology’s first suite of process automation solutions beyond Automated QC.

Our website uses cookies. By using this site, you agree to its use of cookies.